Zhou WJ - Search Results

1

Functional Hexafluoroisopropyl Group Used in the Construction of Biologically Important Pyrimidine Derivatives.

Yuan S, Li X, Zhang YL, Zhou WJ, Du YB, He ZX, Liu HM, Bai YR. Yuan S, et al. Among authors: zhou wj. J Org Chem. 2024 Nov 15;89(22):16485-16492. doi: 10.1021/acs.joc.4c01749. Epub 2024 Oct 31. J Org Chem. 2024. PMID: 39480993

2

Discovery of Potent and Selective 2-(Benzylthio)pyrimidine-based DCN1-UBC12 Inhibitors for Anticardiac Fibrotic Effects.

He ZX, An Q, Wei B, Zhou WJ, Wei BF, Gong YP, Zhang X, Gao G, Dong GJ, Huo JL, Zhang XH, Yang FF, Liu HM, Ma LY, Zhao W. He ZX, et al. Among authors: zhou wj. J Med Chem. 2022 Jan 13;65(1):163-190. doi: 10.1021/acs.jmedchem.1c01207. Epub 2021 Dec 23. J Med Chem. 2022. PMID: 34939411

3

A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects.

Bai YR, Seng DJ, Xu Y, Zhang YD, Zhou WJ, Jia YY, Song J, He ZX, Liu HM, Yuan S. Bai YR, et al. Among authors: zhou wj. Eur J Med Chem. 2024 Oct 5;276:116706. doi: 10.1016/j.ejmech.2024.116706. Epub 2024 Jul 22. Eur J Med Chem. 2024. PMID: 39053188 Review.

4

Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M Interaction.

Zhou W, Ma L, Ding L, Guo Q, He Z, Yang J, Qiao H, Li L, Yang J, Yu S, Zhao L, Wang S, Liu HM, Suo Z, Zhao W. Zhou W, et al. J Med Chem. 2019 Jun 13;62(11):5382-5403. doi: 10.1021/acs.jmedchem.9b00003. Epub 2019 Jun 3. J Med Chem. 2019. PMID: 31157974

5

Novel thiosemicarbazone derivatives containing indole fragment as potent and selective anticancer agent.

He Z, Qiao H, Yang F, Zhou W, Gong Y, Zhang X, Wang H, Zhao B, Ma L, Liu HM, Zhao W. He Z, et al. Eur J Med Chem. 2019 Dec 15;184:111764. doi: 10.1016/j.ejmech.2019.111764. Epub 2019 Oct 7. Eur J Med Chem. 2019. PMID: 31614257

6

Potent hydrazone derivatives targeting esophageal cancer cells.

Li LY, Peng JD, Zhou W, Qiao H, Deng X, Li ZH, Li JD, Fu YD, Li S, Sun K, Liu HM, Zhao W. Li LY, et al. Eur J Med Chem. 2018 Mar 25;148:359-371. doi: 10.1016/j.ejmech.2018.02.033. Epub 2018 Feb 14. Eur J Med Chem. 2018. PMID: 29475156

7

Novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing hydrazone fragment as potent and selective anticancer agents.

Xu C, Zhou W, Dong G, Qiao H, Peng J, Jia P, Li Y, Liu H, Sun K, Zhao W. Xu C, et al. Bioorg Chem. 2020 Dec;105:104424. doi: 10.1016/j.bioorg.2020.104424. Epub 2020 Oct 24. Bioorg Chem. 2020. PMID: 33161253

8

Development of phenyltriazole thiol-based derivatives as highly potent inhibitors of DCN1-UBC12 interaction.

Zhou W, Xu C, Dong G, Qiao H, Yang J, Liu H, Ding L, Sun K, Zhao W. Zhou W, et al. Eur J Med Chem. 2021 May 5;217:113326. doi: 10.1016/j.ejmech.2021.113326. Epub 2021 Mar 12. Eur J Med Chem. 2021. PMID: 33756127

9

A Systematic Review of Histone Lysine-Specific Demethylase 1 and Its Inhibitors.

Zheng YC, Ma J, Wang Z, Li J, Jiang B, Zhou W, Shi X, Wang X, Zhao W, Liu HM. Zheng YC, et al. Med Res Rev. 2015 Sep;35(5):1032-71. doi: 10.1002/med.21350. Epub 2015 May 19. Med Res Rev. 2015. PMID: 25990136 Review.

10

Evaluation of HZX-960, a novel DCN1-UBC12 interaction inhibitor, as a potential antifibrotic compound for liver fibrosis.

Zhou W, Dong G, Gao G, He Z, Xu J, Aziz S, Ma L, Zhao W. Zhou W, et al. Biochem Cell Biol. 2022 Aug 1;100(4):309-324. doi: 10.1139/bcb-2021-0585. Epub 2022 May 11. Biochem Cell Biol. 2022. PMID: 35544948

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

474 results

Search Page

Filters